NCT04375865View on ClinicalTrials.gov

Evaluating the Pharmacokinetic Interactions and Safety Between AD-2111 and AD-2112

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

May 30, 2020

Primary Completion Date

July 16, 2020

Study Completion Date

July 16, 2020

Conditions
Pain
Interventions
DRUG

AD-2111

celecoxib 200mg

DRUG

AD-2112

Tramadol 150mg

Trial Locations (1)

41944

Kyungpook National University Hospital, Daegu

All Listed Sponsors
lead

Addpharma Inc.

INDUSTRY

NCT04375865 - Evaluating the Pharmacokinetic Interactions and Safety Between AD-2111 and AD-2112 | Biotech Hunter | Biotech Hunter